The atherogenic lipoprotein phenotype: Small dense LDL and lipoprotein remnants in nephrotic range proteinuria

Atherosclerosis

Volumn 157, Issue 1, 2001, Pages 211-220

  Deighan, Christopher J ^a   Caslake, Muriel J ^a   McConnell, Michael ^a   Boulton Jones, J Michael ^a   Packard, Christopher J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Atherogenic lipoprotein phenotype; Cardiovascular risk; Low density lipoprotein; Nephrotic range proteinuria; Remnant lipoproteins; Small dense LDL

Indexed keywords

LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME ACTIVITY; FEMALE; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; LIPOPROTEIN BLOOD LEVEL; MALE; NEPHROTIC RANGE PROTREINURIA; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; APOLIPOPROTEINS; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PROTEINURIA; RISK; TRIGLYCERIDES;

EID: 0034977159     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00710-3     Document Type: Article

References (29)

1. The increased risk of coronary heart disease associated with the nephrotic syndrome
2. Lipoprotein metabolism in the nephrotic syndrome
3. Lipid abnormalities in the nephrotic syndrome: Causes, consequences and treatment
4. The nephrotic syndrome, lipids and risk factors for cardiovascular disease
5. The influence of hypoalbuminaemia in the generation of nephrotic hyperlipidaemia
6. Lipoprotein heterogeneity and apolipoprotein B metabolism
7. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk
8. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease
9. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
10. Increased atherogenicity of low-density lipoprotein in heavy proteinuria
11. Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages
12. Predictive value of remnant like particles cholesterol/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease
13. Plasma remnant like particle and apolipoprotein levels in normolipidaemic and hyperlipidaemic subjects
14. The isolation and quantitation analysis of serum lipoproteins
15. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation
16. Selective determination of lipoprotein lipase and hepatic lipase in heparinised plasma from horses
17. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-1 immunoaffinity mixed gels
18. Prediction of creatinine clearance from serum creatinine
19. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (ATP II)
20. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study
21. Metabolism of apolipoprotein B-containing lipoprotein in subjects with nephrotic range proteinuria
22. A simultaneous study of the metabolism of apolipoprotein B and albumin in nephrotic patients
23. Remnant-like particles and restenosis of coronary arteries after PTCA
24. The possible role of remnant-like particles as a risk factor for sudden cardiac death
25. Aggregation of human blood platelets by remnant-like lipoprotein particles of plasma chylomicrons and very low density lipoproteins
26. Impaired endothelial dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles
27. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinaemia or coronary artery disease
28. Low-density lipoprotein particle size distribution in end-stage renal disease treated with haemodialysis or peritoneal dialysis
29. Remnant like particle cholesterol may indicate atherogenic risk in patients on chronic haemodialysis